cathepsin G



cathepsin G

I1II1I2II2G3GG3G4GG4R5RR5E6EE6A7AA7R8RR8P9PP9N10NN10S11SS11H12HH12P13PP13Y14YY14M15MM15A16AA16F17FF17L18LL18L19LL19I20II20G21GG21S22SS22P23PP23E24EE24G25GG25L26LL26S27SS27A28AA28C29CC29G30GG30G31GG31F32FF32L33LL33V34VV34R35RR35E36EE36D37DD37F38FF38V39VV39L40LL40T41TT41A42AA42G43GG43H44HH44C45CC45F46FF46G47GG47... and 183 more residue(s)...... and 183 more residue(s)

SMILES None
InChIKey None
Sequence IIGGREARPNSHPYMAFLLIGSPEGLSACGGFLVREDFVLTAGHCFGSSINVTLGAHNIRRGEGTGGHITVLRAIRHPDYNPPPVIQNDIMLLQLRSRARRSRAVKPVALPQATKRVQPGALCTVAGWGLVSQRRGTNVLQEVKLRVQTDQTCANRFQFYNSQTQICVGNPRERKSAFKGDSGGPLVCNNVAQGIVSYGSSSGNPPAVFTRIQSFMPWIKRTMRRLSSRY

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

cathepsin G

I1II1I2II2G3GG3G4GG4R5RR5E6EE6A7AA7R8RR8P9PP9N10NN10S11SS11H12HH12P13PP13Y14YY14M15MM15A16AA16F17FF17L18LL18L19LL19I20II20G21GG21S22SS22P23PP23E24EE24G25GG25L26LL26S27SS27A28AA28C29CC29G30GG30G31GG31F32FF32L33LL33V34VV34R35RR35E36EE36D37DD37F38FF38V39VV39L40LL40T41TT41A42AA42G43GG43H44HH44C45CC45F46FF46G47GG47... and 183 more residue(s)...... and 183 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.